Investment

Evelo Biosciences, Horizon Technology Finance Sign Forbearance Agreement

1 Mins read

By Sabela Ojea


Evelo Biosciences and Horizon Technology Finance have entered a forbearance agreement, according to a Securities and Exchange Commission filing.

Clinical stage biotechnology company Evelo on Friday said that Horizon agreed to forbear exercising remedies related to potential defaults through Dec. 15.

Evelo Biosciences said it paid down $11 million of the principal amount of the loans outstanding and amended the mandatory prepayment provision of the loan agreement.


Write to Sabela Ojea at [email protected]; @sabelaojeaguix


Read the full article here

Related posts
Investment

The winner of EA’s ‘Madden’ videogame tournament will get more prize money than the NFL’s Super Bowl champions

1 Mins read
Last Updated: March 3, 2025 at 10:21 p.m. ETFirst Published: March 3, 2025 at 4:58 p.m. ET Kids who are obsessed with football may…
Investment

AMC’s most liquid bond is rallying following the movie-theater chain’s fourth-quarter results

1 Mins read
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue…
Investment

The world’s biggest dividend has just been cut. Here’s why.

1 Mins read
Published: March 4, 2025 at 3:51 a.m. ET Saudi Arabian Oil Co. has slashed its massive dividend payout — the world’s biggest —…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *